Jpmorgan Chase & CO Evolent Health, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Evolent Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,190,445 shares of EVH stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,190,445
Previous 4,116,045 22.49%
Holding current value
$30 Million
Previous $116 Million 69.17%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$10.71 - $27.14 $9.91 Million - $25.1 Million
-925,600 Reduced 22.49%
3,190,445 $35.9 Million
Q3 2024

Dec 26, 2024
SELL
$18.41 - $32.97 $4.39 Million - $7.87 Million
-238,695 Reduced 5.48%
4,116,045 $116 Million
Q3 2024

Nov 08, 2024
SELL
$18.41 - $32.97 $4.39 Million - $7.87 Million
-238,695 Reduced 5.48%
4,116,045 $116 Million
Q2 2024

Dec 26, 2024
BUY
$19.12 - $31.93 $4.56 Million - $7.62 Million
238,695 Added 5.8%
4,354,740 $83.3 Million
Q2 2024

Aug 12, 2024
SELL
$19.12 - $31.93 $7.5 Million - $12.5 Million
-392,367 Reduced 8.27%
4,354,740 $83.3 Million
Q1 2024

Dec 26, 2024
BUY
$29.41 - $34.72 $18.6 Million - $21.9 Million
631,062 Added 15.33%
4,747,107 $156 Million
Q1 2024

May 10, 2024
SELL
$29.41 - $34.72 $34.4 Million - $40.6 Million
-1,170,577 Reduced 19.78%
4,747,107 $156 Million
Q4 2023

Dec 26, 2024
BUY
$23.63 - $33.52 $42.6 Million - $60.4 Million
1,801,639 Added 43.77%
5,917,684 $195 Million
Q4 2023

Feb 12, 2024
SELL
$23.63 - $33.52 $3.09 Million - $4.38 Million
-130,802 Reduced 2.16%
5,917,684 $195 Million
Q3 2023

Nov 14, 2023
BUY
$25.0 - $31.4 $4.47 Million - $5.62 Million
178,993 Added 3.05%
6,048,486 $165 Million
Q2 2023

Aug 11, 2023
BUY
$28.05 - $36.44 $8.67 Million - $11.3 Million
308,943 Added 5.56%
5,869,493 $178 Million
Q1 2023

May 18, 2023
BUY
$26.35 - $35.8 $2.83 Million - $3.84 Million
107,216 Added 1.97%
5,560,550 $180 Million
Q1 2023

May 11, 2023
BUY
$26.35 - $35.8 $2.52 Million - $3.42 Million
95,458 Added 1.78%
5,453,334 $177 Million
Q4 2022

Feb 13, 2023
SELL
$22.21 - $37.41 $10.8 Million - $18.3 Million
-488,129 Reduced 8.35%
5,357,876 $150 Million
Q3 2022

Nov 14, 2022
SELL
$29.37 - $39.74 $7.44 Million - $10.1 Million
-253,244 Reduced 4.15%
5,846,005 $210 Million
Q2 2022

Aug 11, 2022
SELL
$25.9 - $32.26 $1.03 Million - $1.29 Million
-39,843 Reduced 0.65%
6,099,249 $187 Million
Q1 2022

May 11, 2022
BUY
$22.14 - $32.3 $849,378 - $1.24 Million
38,364 Added 0.63%
6,139,092 $198 Million
Q4 2021

Feb 10, 2022
SELL
$25.36 - $34.11 $2.76 Million - $3.71 Million
-108,769 Reduced 1.75%
6,100,728 $169 Million
Q3 2021

Nov 12, 2021
BUY
$20.93 - $31.0 $130 Million - $192 Million
6,209,497 New
6,209,497 $192 Million

Others Institutions Holding EVH

# of Institutions
286
Shares Held
118M
Call Options Held
1.44M
Put Options Held
1.07M
View Full List

About Evolent Health, Inc.

EVH Quotes by TradingView
  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $911M
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email